Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis

Journal of Experimental Medicine

Volumn 207, Issue 8, 2010, Pages 1609-1616

  Cruz, Andrea ^a   Fraga, Alexandra G ^a   Fountain, Jeffrey J ^b   Rangel Moreno, Javier ^c   Torrado, Egídio ^b   Saraiva, Margarida ^a   Pereira, Daniela R ^a   Randall, Troy D ^c   Pedrosa, Jorge ^a   Cooper, Andrea M ^b   Castro, António G ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b TRUDEAU INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 23P19; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR; CELL SURFACE RECEPTOR; CXCL2 CHEMOKINE; GRANULOCYTE RECEPTOR 1, MOUSE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC CODE; GRANULOCYTE; IMMUNOPATHOLOGY; LUNG GRANULOMA; LUNG INJURY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUBERCULOSIS; ANIMAL; C57BL MOUSE; CELL COUNT; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GRANULOMA; HELPER CELL; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LUNG; LYMPH NODE; METABOLISM; NEUTROPHIL; PATHOLOGY; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BCG VACCINE; CELL COUNT; CELL MOVEMENT; CHEMOKINE CXCL2; FEMALE; GENE EXPRESSION; GRANULOCYTES; GRANULOMA; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKIN-6; LUNG; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES, HELPER-INDUCER; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 77955390095     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100265     Document Type: Article

References (31)

1. Colditz, G.A., T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 271:698-702. doi:10.1001/jama.271.9.698
2. Cruz, A., S.A. Khader, E. Torrado, A. Fraga, J.E. Pearl, J. Pedrosa, A.M. Cooper, and A.G. Castro. 2006. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177:1416-1420. (Pubitemid 44092473)
3. Desvignes, L., and J.D. Ernst. 2009. Interferon-γ-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity. 31:974-985. doi:10.1016/j.immuni.2009.10.007
4. Dye, C. 2006. Global epidemiology of tuberculosis. Lancet. 367:938-940. doi:10.1016/S0140-6736(06)68384-0
5. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione. 1999. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country. JAMA. 282:677-686. doi:10.1001/jama.282.7.677 (Pubitemid 29384157)
6. Eruslanov, E.B., I.V. Lyadova, T.K. Kondratieva, K.B. Majorov, I.V. Scheglov, M.O. Orlova, and A.S. Apt. 2005. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect. Immun. 73:1744-1753. doi:10.1128/IAI.73.3.1744-1753.2005 (Pubitemid 40470763)
7. Eum, S.Y., J.H. Kong, M.S. Hong, Y.J. Lee, J.H. Kim, S.H. Hwang, S.N. Cho, L.E. Via, and C.E. Barry III. 2010. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 137:122-128. doi:10.1378/chest.09-0903
8. Huygen, K., E. Lozes, B. Gilles, A. Drowart, K. Palfliet, F. Jurion, I. Roland, M. Art, M. Dufaux, J. Nyabenda, et al. 1994. Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect. Immun. 62:363-370. (Pubitemid 24033750)
9. Keller, C., R. Hoffmann, R. Lang, S. Brandau, C. Hermann, and S. Ehlers. 2006. Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect. Immun. 74:4295-4309. doi:10.1128/IAI.00057-06 (Pubitemid 43993363)
10. Khader, S.A., and A.M. Cooper. 2008. IL-23 and IL-17 in tuberculosis. Cytokine. 41:79-83. doi:10.1016/j.cyto.2007.11.022
11. Khader, S.A., J.E. Pearl, K. Sakamoto, L. Gilmartin, G.K. Bell, D.M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A.M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigenspecific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175:788-795.
12. Khader, S.A., G.K. Bell, J.E. Pearl, J.J. Fountain, J. Rangel-Moreno, G.E. Cilley, F. Shen, S.M. Eaton, S.L. Gaffen, S.L. Swain, et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377. doi:10.1038/ni1449
13. Koch, R. 1891. Fortsetzung der mittheilung über ein heilmittel gegen tuberculose. Dtsch. Med. Wochenschr. 17:101-102. doi:10.1055/s-0029-1206198
14. Kolls, J.K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity. 21:467-476. doi:10.1016/j.immuni.2004.08.018
15. McGeachy, M.J., and D.J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity. 28:445-453. doi:10.1016/j.immuni.2008.03.001 (Pubitemid 351467042)
16. Miyamoto, M., O. Prause, M. Sjöstrand, M. Laan, J. Lötvall, and A. Lindén. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170:4665-4672. (Pubitemid 36519973)
17. Moreira, A.L., L. Tsenova, M.H. Aman, L.G. Bekker, S. Freeman, B. Mangaliso, U. Schröder, J. Jagirdar, W.N. Rom, M.G. Tovey, et al. 2002. Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice. Infect. Immun. 70:2100-2107. doi:10.1128/IAI.70.4. 2100-2107.2002
18. North, R.J., and Y.J. Jung. 2004. Immunity to tuberculosis. Annu. Rev. Immunol. 22:599-623. doi:10.1146/annurev.immunol.22.012703.104635
19. Redford, P.S., A. Boonstra, S. Read, J. Pitt, C. Graham, E. Stavropoulos, G. Bancroft, and A. O'Garra. 2010. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by an earlier and enhanced Th1 response in the lung. Eur. J. Immunol. doi:10.1002/eji.201040433.
20. Rich, A. 1944. The Pathogenesis of Tuberculosis. Charles C. Thomas, Publisher, Ltd., Baltimore. 1008 pp.
21. Roberts, A., A. Cooper, J. Belisle, J. Turner, M. Gonzalez-Juarerro, and I. Orme. 2002. Murine models of tuberculosis. In Methods in Microbiology. S. Kaufmann and D. Kabelitz, editors. Academic Press, London. 433-462.
22. Sander, C.R., A.A. Pathan, N.E. Beveridge, I. Poulton, A. Minassian, N. Alder, J. Van Wijgerden, A.V. Hill, F.V. Gleeson, R.J. Davies, et al. 2009. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am. J. Respir. Crit. Care Med. 179:724-733. doi:10.1164/rccm.200809-1486OC
23. Stark, M.A., Y. Huo, T.L. Burcin, M.A. Morris, T.S. Olson, and K. Ley. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 22:285-294. doi:10.1016/j.immuni.2005.01.011
24. Sterne, J.A., L.C. Rodrigues, and I.N. Guedes. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2:200-207. (Pubitemid 28123518)
25. Taylor, J.L., O.C. Turner, R.J. Basaraba, J.T. Belisle, K. Huygen, and I.M. Orme. 2003. Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect. Immun. 71:2192-2198. doi:10.1128/IAI.71.4.2192-2198.2003
26. Torchinsky, M.B., J. Garaude, A.P. Martin, and J.M. Blander. 2009. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature. 458:78-82. doi:10.1038/nature07781
27. Torrado, E., A.G. Fraga, E. Logarinho, T.G. Martins, J.A. Carmona, J.B. Gama, M.A. Carvalho, F. Proença, A.G. Castro, and J. Pedrosa. 2010. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone. J. Immunol. 184:947-955.
28. Turner, J., E.R. Rhoades, M. Keen, J.T. Belisle, A.A. Frank, and I.M. Orme. 2000. Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode. Infect. Immun. 68:1706-1709. doi:10.1128/IAI.68.3.1706-1709.2000 (Pubitemid 30108577)
29. Umemura, M., A. Yahagi, S. Hamada, M.D. Begum, H. Watanabe, K. Kawakami, T. Suda, K. Sudo, S. Nakae, Y. Iwakura, and G. Matsuzaki. 2007. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178:3786-3796.
30. Weir, R.E., P. Gorak-Stolinska, S. Floyd, M.K. Lalor, S. Stenson, K. Branson, R. Blitz, A. Ben-Smith, P.E. Fine, and H.M. Dockrell. 2008. Persistence of the immune response induced by BCG vaccination. BMC Infect. Dis. 8:9. doi:10.1186/1471-2334-8-9
31. Zelante, T., A. De Luca, P. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti, M.L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695-2706. doi:10.1002/eji.200737409